A Conversation With Liz Risenberg of Lumenis - Report - MDSpire

A Conversation With Liz Risenberg of Lumenis

  • By

  • Julie Greenbaum, editor

  • January 1, 2026

  • 4 min

Share

Clinical Report: Lumenis Launches OptiLIFT Device for Lower Lid Laxity

Overview

The OptiLIFT device utilizes Dynamic Muscle Stimulation Technology to strengthen facial muscles around the eyes, addressing lower lid laxity and impaired blinking. Clinical studies indicate significant improvements in tear breakup time and eyelid appearance following treatment.

Background

Lower lid laxity is a common issue in aging populations, leading to impaired blinking and increased risk of dry eye symptoms. Traditional treatments have often been surgical or inadequate, highlighting the need for innovative, non-invasive solutions. The introduction of OptiLIFT represents a significant advancement in addressing both functional and aesthetic concerns in ophthalmology.

Data Highlights

OutcomeImprovement
Lower Lid Laxity75% decrease
Tear Breakup Time286% improvement
Eyelid Appearance60% improvement
Blinking Quality70% improvement

Key Findings

  • OptiLIFT strengthens periorbital muscles, addressing lower lid laxity.
  • Dynamic Muscle Stimulation Technology (DMSt) activates facial muscles through electrical pulses.
  • Clinical studies show significant improvements in tear breakup time and eyelid appearance.
  • 60% of symptomatic dry eye patients experience impaired lid closure.
  • OptiLIFT offers a non-surgical alternative to blepharoplasty for lower lid laxity.

Clinical Implications

The OptiLIFT device provides ophthalmologists with a new tool to enhance patient outcomes for those suffering from lower lid laxity and dry eye symptoms. Its non-invasive nature and significant efficacy in improving eyelid function and appearance may reduce the need for surgical interventions.

Conclusion

The launch of the OptiLIFT device marks a pivotal development in the management of lower lid laxity and dry eye symptoms, offering a promising non-surgical treatment option for patients.

References

  1. Doan S, Zagórski Z, Palmares J, et al., Ophthalmol Ther, 2020 -- Eyelid disorders in ophthalmology practice: results from a large international epidemiological study in eleven countries
  2. Chelnis JG, Chelnis A., Clin Ophthalmol, 2025 -- Dynamic muscle stimulation of the periorbital area for improvement of blinking in dry eye patients
  3. Korb D, Blackie C, Nau A., Invest Ophthalmol Vis Sci, 2017 -- Prevalence of compromised lid seal in symptomatic refractory dry eye patients and asymptomatic patients
  4. Korb DR, Blackie CA., Invest Ophthalmol Vis Sci, 2016 -- Treating inadequate lid seal in patients with dry eye using an overnight ointment reduces discomfort upon awakening and overall dry eye symptoms
  5. Ophthalmology Management — Spotlight on Technology & Technique: Double Teaming Dry Eye
  6. Retinal Physician — NEW PRODUCT APPLICATIONS: Making Laser Indirect Ophthalmoscopy New Again
  7. Ophthalmology Management — Lumenis Launches OptiLIFT Device to Address Lower Lid Laxity, Impaired Blinking
  8. Ophthalmology Management — INDUSTRY INSIDER
  9. Lumenis Launches OptiLIFT Device to Address Lower Lid Laxity, Impaired Blinking
  10. Spotlight on Technology & Technique: Double Teaming Dry Eye
  11. Dry Eye Syndrome Preferred Practice Pattern®
  12. DEN200028 Lumenis Stellar M22

Original Source(s)

Related Content